Asia-Pacific Drugs, Health and Beauty Retailers Benchmarked in New Topical Report Available at MarketPublishers.com
01 Mar 2012 • by Natalie Aster
LONDON – The Asia-Pacific drugs, health and beauty retail channel is highly fragmented and, in many countries, dominated by small independent family stores. Japan is a notable exception to this and the country’s drugs, health and beauty retail channel is moderately concentrated.
SUNDRUG was the strongest performer of the leading drug, health and beauty retailers in Asia-Pacific. The company’s strong performance was driven by the high scores it received for operational efficiency pillar. Meanwhile China’s Nepstar was the weakest performer within the industry.
New market research report "Leading Asia-Pacific Drugs, Health and Beauty Retailers – Company Benchmarking Analysis Report" designed by Canadean presents a peer group benchmarking analysis of leading drug, health and beauty retailers in Asia-Pacific. The analysis is based on key financial and operating parameters and ratios of a select peer group of companies, compared to one another and to overall global averages for their retail channel. The analysis highlights the companies that are performing the best among the peer group, and in which areas, and therefore clarifies leading performance standards and the strengths and weaknesses of companies covered.
The companies reviewed in the report are:
- Matsumotokiyoshi Holdings Co., Ltd.
- SUGI Holdings Co., Ltd.
- TSURUHA HOLDINGS INC.
- SUNDRUG CO., LTD.
- NIHON CHOUZAI Co., Ltd.
- YAKUODO. Co., Ltd.
- China Nepstar Chain Drugstore Ltd.
Leading Asia-Pacific Drugs, Health and Beauty Retailers – Company Benchmarking Analysis Report
Published: February, 2012
Price: US$ 1.950,00
More new market research reports by the publisher can be found at Canadean page.